In addition, they found ERO1L and NARS to be positively associated with lymph node metastasis, in which ERO1L overexpression in patients with early-stage adenocarcinoma was associated with poor overall survival. This evidence concerns the gene ERO1A and metastatic malignant neoplasm in the lymph nodes.